Announces that Mr. Babak Pedram has joined its Board of Directors. Mr. Pedram is a seasoned capital market professional with over 15 years of experience as an investment banker, investor relations, and capital markets advisor to numerous biotech, healthcare and technology companies based in Canada, the United States and Sweden. Mr. Pedram is the founder and president of Virtus Advisory Group, a Toronto-based capital markets advisory firm. He is also the co-founder of several successful start-ups, including two publicly traded companies listed on the Toronto Stock Exchange. Marvel Biosciences Corp shares V.MRVL are trading down one cent at $0.14.